Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00894673

Completed

Efficacy and Safety of Sodium Heparin (Hipolabor) in Patients (HEPSBCCV0109)

Cardiac Surgery
NCT00320788

Completed

Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)

Macular Degeneration
NCT01449552

Completed

Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT

Osteoarthritis of Knee
NCT00502112

Completed

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome (MDS)
NCT00785018

Completed

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia (VECTOR)

Inflammation | Endotoxemia | Multi Organ Dysfunction Syndrome
NCT00175695

Completed

Disease Modification in Toxaemia of Pregnancy

Pre-eclampsia
NCT00081757

Completed

An Open Protocol for the Compassionate Use of Thalidomide

Multiple Myeloma
NCT00209014

Terminated

Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease

B-Cell Lymphoma | Hodgkin's Disease
NCT07389057

Recruiting

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Malaria Infection | Malaria Asymptomatic Parasitaemia | Malaria Falciparum | Malaria Transmission
NCT07328438

Not yet recruiting

Diagnosis Disclosure Support for Caregivers of Children With Autism

Autism Spectrum Disorder
NCT06013046

Recruiting

Wheelchair User Physical Activity Training Intervention to Enhance Cardiometabolic Health (WATCH)

Physical Disability
NCT07228637

Active, not recruiting

Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer (PERSIST)

Testicular Cancer
NCT03506867

Enrolling by invitation

Healthy People Initiative (HPI) (HPI)

Substance Use Disorders | Nicotine Dependence
NCT07090525

Recruiting

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Overall Response Rate
NCT06669143

Not yet recruiting

Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission

Diffuse Large B Cell Lymphoma
NCT05976568

Not yet recruiting

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT05904457

Recruiting

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer (BRISK)

Advanced Solid Tumors | Metastatic Cancer | Solid Tumors
NCT05585814

Recruiting

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer (COBP)

Locally Advanced Colorectal Cancer
NCT05516628

Recruiting

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma (EMPHASIS)

Hepatocellular Carcinoma
NCT05277675

Recruiting

Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study) (RANT)

Hepatocellular Carcinoma Recurrent
NCT04988607

Not yet recruiting

Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC

Lung Cancer
NCT04734665

Recruiting

Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor (NIRVANA-R)

Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
NCT03890952

Completed

Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

Recurrent Adult Brain Tumor
NCT02017717

Completed

A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients (CheckMate 143)

Recurrent Glioblastoma
NCT02307812

Approved for marketing

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma
NCT06666582

Completed

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Gastric Cancer Stage IV | Second-line Treatment | Ramucirumab Paclitaxel
NCT02443324

Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Carcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal Junction
NCT03376659

Terminated

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Metastatic Colorectal Cancer | Pancreatic Adenocarcinoma | Colorectal Adenocarcinoma | Metastatic Pancreatic Cancer
NCT03434379

Completed

A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave150)

Carcinoma, Hepatocellular
NCT01606098

Completed

The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer (CAIRO4)

Rectal Cancer | Colon Cancer | Primary Tumour
NCT01745757

Completed

Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer (COMET)

Breast Cancer | Metastatic
NCT04976543

Completed

Safety of Anticoagulant Therapy After Endoscopic Treatment

Cirrhosis | Esophageal and Gastric Varices | Portal Vein Thrombosis | Anticoagulant-induced Bleeding
NCT02749526

Terminated

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

Esophageal
NCT05360342

Completed

Incorporation of Vitamin K Into Uremic Lipoproteins

Vitamin K Deficiency
NCT00867321

Completed

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Liver Cancer
NCT03176264

Terminated

PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer

Metastatic Colorectal Cancer
NCT00590681

Completed

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme
NCT04173429

Completed

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Liver Cirrhosis | Portal Vein Thrombosis
NCT00130728

Completed

A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer
NCT03509922

Completed

A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Peripheral Artery Disease, PAD
NCT04425187

Unknown

Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC

PFS
NCT00795665

Completed

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Glioma
NCT00445848

Completed

S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer

Lung Cancer
NCT02935985

Completed

Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers (EsICH)

Cerebral Hemorrhage
NCT03573622

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Healthy
NCT03862768

Unknown

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Surgery | Gastrointestinal Stromal Tumors
NCT03649945

Unknown

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

Esophageal Cancer
NCT00824538

Terminated

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Breast Cancer
NCT00943826

Completed

A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Glioblastoma
NCT00345163

Completed

A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN) (BRAIN)

Glioblastoma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations